Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Dynamiker Biotechnology (Tianjin) Co PB Ratio?
Dynamiker Biotechnology (Tianjin) CoBJSE:920009 46 PB Ratio is 3.92 as of Aug. 20, 2026, which is 28% below its 10-year median of 5.41. GuruFocus rates BJSE:920009 with a GF Score™ of 46/100. The stock has 3 warning signs investors should review. Among 916 Drug Manufacturers companies, Dynamiker Biotechnology (Tianjin) Co ranks worse than 75.66% on this metric.
BJSE:920009's PB Ratio is ranked worse than 75.66% of 916
companies
in the Drug Manufacturers industry
Industry Median: 1.965
vs BJSE:920009: 3.92
During the past 12 months, Dynamiker Biotechnology (Tianjin) Co's average Book Value Per Share Growth Rate was 41.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 33.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 31.10% per year.
During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Dynamiker Biotechnology (Tianjin) Co was 53.50% per year. The lowest was 27.30% per year. And the median was 34.55% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Dynamiker Biotechnology (Tianjin) Co PB Ratio Related Terms
Dynamiker Biotechnology (Tianjin) Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamiker Biotechnology (Tianjin) Co PB Ratio Chart
BJSE:920009 vs LLY, JNJ, ABBV: PB Ratio Comparison
For the Drug Manufacturers - General subindustry, Dynamiker Biotechnology (Tianjin) Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamiker Biotechnology (Tianjin) Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dynamiker Biotechnology (Tianjin) Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Dynamiker Biotechnology (Tianjin) Co's PB Ratio falls into.
Dynamiker Biotechnology (Tianjin) Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a PB Ratio of 3.92 as of Aug. 20, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. This is 28% below median its historical median of 5.41. Over the past decade, Dynamiker Biotechnology (Tianjin) Co's PB Ratio has ranged from 3.69 to 9.80. According to the industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #693 out of 916 companies in the Drug Manufacturers industry, placing it in the top 75.7%.
Is Dynamiker Biotechnology (Tianjin) Co's PB Ratio too high?
Dynamiker Biotechnology (Tianjin) Co's current PB Ratio of 3.92 is 28% below median its 10-year median of 5.41. Over the past 10 years, this metric has ranged from a low of 3.69 to a high of 9.80. The Drug Manufacturers industry median PB Ratio is 1.97. Dynamiker Biotechnology (Tianjin) Co's value of 3.92 is 99.5% above this industry median. Based on the distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #693 out of 916 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Dynamiker Biotechnology (Tianjin) Co has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Dynamiker Biotechnology (Tianjin) Co's PB Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #693 out of 916 companies for PB Ratio. This places Dynamiker Biotechnology (Tianjin) Co in the lower half of its industry. The industry median PB Ratio is 1.97. Dynamiker Biotechnology (Tianjin) Co's value of 3.92 is 99.5% above this benchmark. Historically, Dynamiker Biotechnology (Tianjin) Co's own PB Ratio has ranged from 3.69 to 9.80 over the past decade. While the company's 10-year median is 5.41 vs. the industry median of 1.97, Dynamiker Biotechnology (Tianjin) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.97, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynamiker Biotechnology (Tianjin) Co's current PB Ratio of 3.92 is 99.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamiker Biotechnology (Tianjin) Co's current PB Ratio is 3.92, which is 28% below median its own 10-year median of 5.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamiker Biotechnology (Tianjin) Co stock overvalued right now?
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a current PB Ratio of 3.92. The current PB Ratio is 3.92, which is 28% below median its 10-year median of 5.41 and 99.5% above the Drug Manufacturers industry median of 1.97. Dynamiker Biotechnology (Tianjin) Co's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Dynamiker Biotechnology (Tianjin) Co (BJSE:920009), the current PB Ratio is 3.92 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dynamiker Biotechnology (Tianjin) Co Ltd specializes in R&D, production, and sales of early serological diagnosis of invasive mycosis and in vitro diagnostic products for other pathogenic microorganisms.
46GF Score
Get the complete analysis for BJSE:920009
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920009 has been successfully added to your 
